Filana Therapeutics Inc (SAVA) Live Share Price, Invest From India

Filana Therapeutics Inc Stock Performance

as on March 11, 2026 at 6:59 am IST

Day's Low
Day's High
$2.19
Day's Price Range
$2.49
$2.38
7.98%
Downside
4.62%
Upside
52 Week's Low
52 Week's High
$1.75
52-Week Price Range
$4.98
$2.38
26.47%
Downside
109.24%
Upside

Filana Therapeutics Inc share price movements today

Previous Close: $2.12
Open: $2.19
Volume: 2.5M
Day's Low - High: $2.19 - $2.49
52 Week Low - High: $1.75 - $4.98

Filana Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Filana Therapeutics Inc Stock Fundamentals & Key Indicators

Check Filana Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Filana Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Filana Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Filana Therapeutics Inc	BUY	$-	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.7B	75.37%	74.61	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$113.1B	130.57%	26.46	35.51%	NA
BeiGene, Ltd.	NA	$27.3B	NA	59.51	8.94%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.6B	16.35%	15.04	29.65%	0.59%

Analyst Recommendation on Filana Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Filana Therapeutics Inc. Average target price of $8

Filana Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Filana Therapeutics Inc.

What analysts predicted

70.25%UPSIDE

Target Price

Current Price

$2.38

Analyzed by

8 Analysts

Target

$8.00

Filana Therapeutics Inc target price $8, a slight upside of 70.25% compared to current price of $2.38. According to 8 analysts rating.

Filana Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	2	-	-	-	1	-	-	0	-
Gross Profit	-23	-18	-16	-15	-17	-20	-13	-5	0	18
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-25	-20	25	6	-27	-27	-23	-44	-10	-12
Net Profit Margin	0.00%	-890.93%	0.00%	0.00%	0.00%	-2258.35%	0.00%	0.00%	-1286.55%	0.00%

Filana Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	0	-	-	-
Gross Profit	-9	-7	-2	-1	-3	0	0	-89	-1	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-14	-11	-6	-4	-6	-31	-72	-97	-24	-90
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4026222.22%	0.00%	0.00%	0.00%

Global Institutional Holdings in Filana Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	4.92%
GMT Capital Corp	0.93%
BlackRock Inc	2.92%
Geode Capital Management, LLC	1.13%
GSA Capital Partners LLP	0.6%

See all

Insights on Filana Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 53.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 77.2% return, outperforming this stock by 168.7%
NEGATIVE IMPACT
Price Dip
In the last 3 years, SAVA stock has moved down by -91.5%

About Filana Therapeutics Inc

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, investigational treatments for central nervous system disorders, including Alzheimer’s disease and tuberous sclerosis complex (TSC)-related seizures. The Company's science is based on stabilizing, but not removing, a critical protein in the brain for patients with disorders such as Alzheimer’s disease or TSC. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease and TSC-related epilepsy. Simufilam targets an altered form of a protein called filamin A (FLNA) in the brain of patients with disorders such as Alzheimer’s disease or TSC. SavaDx, its lead investigational diagnostic product candidate, early-stage program focused on detecting the presence of Alzheimer’s disease from a small sample of blood.

Organisation	Filana Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Filana Therapeutics Inc share price today?

Filana Therapeutics Inc share price today is $2.38 as on March 11, 2026 at 1:29 am IST at the close of the market. Filana Therapeutics Inc share today touched a day high of $2.49 and a low of $2.19.

What is the 52 week high and 52 week low for Filana Therapeutics Inc share?

Filana Therapeutics Inc share touched a 52 week high of $4.98 on October 16, 2025 and a 52 week low of $1.75 on June 27, 2025. Filana Therapeutics Inc stock price today i.e. March 11, 2026 at 1:29 am IST is closed at $2.38,which is 52.21% down from its 52 week high and 36.00% up from its 52 week low.

How to invest in Filana Therapeutics Inc Stock (SAVA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Filana Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Filana Therapeutics Inc Shares that will get you 0.6303 shares as per Filana Therapeutics Inc share price of $2.38 per share as on March 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Filana Therapeutics Inc Stock (SAVA) from India?

Indian investors can start investing in Filana Therapeutics Inc (SAVA) shares with as little as ₹95.1 or $1 (as of June 13, 2026 at 6:52 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹951.00 in Filana Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on June 13, 2026 at 6:52 am IST). Based on Filana Therapeutics Inc share’s latest price of $2.38 as on March 11, 2026 at 1:29 am IST, you will get 4.2017 shares of Filana Therapeutics Inc. Learn more about fractional shares .